825 INDUSTRIAL ROAD, SAN CARLOS, CA
News, Articles of Incorporation, Bylaws
Enters into Agreement to Be Acquired for $0.33 in Cash per Share
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Provides Business Update and Reports Fourth Quarter 2024 Financial Results
Investor Presentation
Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
Material disclosure
Earnings Release
Q1
Amended Annual Report
FY 2024
Q3
Q2
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
S-8 POS